Press Releases

Read: AION Labs, In Continued Partnership with BioMed X, Launches New Global Call for Applications: Identification of Active Small Molecules for Drug Discovery

AION Labs, In Continued Partnership with BioMed X, Launches New Global Call for Applications: Identification of Active Small Molecules for Drug Discovery

• May 25, 2023

Read: BioMed X Launches XSeed Labs in the US with Boehringer Ingelheim – a New Model for Building an External Innovation Ecosystem on an Industry Campus

BioMed X Launches XSeed Labs in the US with Boehringer Ingelheim – a New Model for Building an External Innovation Ecosystem on an Industry Campus

• Apr 27, 2023

Read: BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies

BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies

• Apr 4, 2023

Read: BioMed X Launches New T Cell Immunology Discovery Platform

BioMed X Launches New T Cell Immunology Discovery Platform

• Feb 14, 2023

Read: BioMed X and AbbVie Extend Research Collaboration in the US

BioMed X and AbbVie Extend Research Collaboration in the US

• Jan 16, 2023

Read: BioMed X Inks Research Collaboration with Sanofi on Artificial Intelligence for Drug Development

BioMed X Inks Research Collaboration with Sanofi on Artificial Intelligence for Drug Development

• Oct 24, 2022

Read: BioMed X Institute and Healthcare Business of Merck KGaA, Darmstadt, Germany, Start New Research Project in Oncology

BioMed X Institute and Healthcare Business of Merck KGaA, Darmstadt, Germany, Start New Research Project in Oncology

• Aug 1, 2022

Read: AION Labs, in Continued Partnership with BioMed X, Launches Fourth Global Call for Application: Prediction of Clinical Trial Outcome in Cancer Patient Populations

AION Labs, in Continued Partnership with BioMed X, Launches Fourth Global Call for Application: Prediction of Clinical Trial Outcome in Cancer Patient Populations

• Jun 29, 2022

Read: BioMed X Institute Launches Ukraine Refugee Funding Program

BioMed X Institute Launches Ukraine Refugee Funding Program

• May 18, 2022

Read: BioMed X Institute and Merck KGaA, Darmstadt, Germany, start second research project in immunology

BioMed X Institute and Merck KGaA, Darmstadt, Germany, start second research project in immunology

• Mar 15, 2022

Read: BioMed X Institute and Boehringer Ingelheim start new research project in brain sensor development

BioMed X Institute and Boehringer Ingelheim start new research project in brain sensor development

• Mar 1, 2022

Read: AION Labs, Powered by BioMed X, Launches Third Global Call for Application: Artificial Intelligence for Design and Optimization of Antibodies for Targeted Therapies

AION Labs, Powered by BioMed X, Launches Third Global Call for Application: Artificial Intelligence for Design and Optimization of Antibodies for Targeted Therapies

• Feb 14, 2022

Read: BioMed X Institute and Merck KGaA, Darmstadt, Germany, extend collaboration in oncology

BioMed X Institute and Merck KGaA, Darmstadt, Germany, extend collaboration in oncology

• Feb 1, 2022

Read: AION Labs, Powered by BioMed X, Launches Second Global Call for Application: Artificial Intelligence for Clinical Trial Readiness of Drug Candidates

AION Labs, Powered by BioMed X, Launches Second Global Call for Application: Artificial Intelligence for Clinical Trial Readiness of Drug Candidates

• Dec 13, 2021

Read: BioMed X Institute successfully completes fourth project in oncology in collaboration with Merck KGaA, Darmstadt, Germany

BioMed X Institute successfully completes fourth project in oncology in collaboration with Merck KGaA, Darmstadt, Germany

• Nov 2, 2021

Read: AION Labs, Powered by BioMed X, Launches First Global Call for Application: Artificial Intelligence for Antibody Design

AION Labs, Powered by BioMed X, Launches First Global Call for Application: Artificial Intelligence for Antibody Design

• Oct 19, 2021

Read: AION Labs, Biotech Innovation Lab Launched by Top Pharma, Tech and Investment Leaders

AION Labs, Biotech Innovation Lab Launched by Top Pharma, Tech and Investment Leaders

• Oct 13, 2021

Read: BioMed X Institute today announces two new research groups in autoimmunity and drug delivery in collaboration with Janssen

BioMed X Institute today announces two new research groups in autoimmunity and drug delivery in collaboration with Janssen

• Aug 2, 2021

Read: BioMed X and Merck KGaA, Darmstadt, Germany launch new research program in oncology

BioMed X and Merck KGaA, Darmstadt, Germany launch new research program in oncology

• Jul 5, 2021

Read: BioMed X Institute and Merck Extend Collaboration to Continue Novel Research in Oncology and Autoimmunity

BioMed X Institute and Merck Extend Collaboration to Continue Novel Research in Oncology and Autoimmunity

• May 17, 2021

Read: BioMed X Institute launches new global call in neuroscience in collaboration with Boehringer Ingelheim

BioMed X Institute launches new global call in neuroscience in collaboration with Boehringer Ingelheim

• Mar 29, 2021